Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/9da4f887-0a30-4ca7-b169-17923f1ad3f7/
GKSL
GUJARAT KIDNEY N SUP SP LSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
8.0%ile
P/E
60.6×
P/S
10.9×
P/B
4.1×
E/P
0.0165
FCF Yield
-0.150
EBITDA/EV
0.029
SH Yield
-0.243
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
87.00000000
/100 — 1=cheapest
VC2 (Trending Value)
94.00000000
/100
VC3 (Buyback)
94.00000000
/100
P/E of 60.6x is premium-priced — the market is paying up for expected growth. Negative FCF yield (-15.0%) — the business is currently cash-consumptive. VC2 score of 94.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
16.0%ile
ROE
0.068
ROA
0.057
Net Margin
0.180
Op Margin
0.254
GPA
0.280
Current
3.76
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
1.038
Earn Growth
0.646
Stability
0.655
lower=better
Accruals
0.070
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
54.0%ile
Vol 252d
34.0%
Vol 60d
40.6%
↑ Expanding
Max DD 12M
-10.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.05
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 160 peers
Sector Value %ile
17.4%
Sector Quality %ile
14.3%
P/E z-score
-0.09
P/B z-score
-0.30
Sector Avg OS
44.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
| Symbol | Name | OS | Value | Quality | Momentum |
|---|---|---|---|---|---|
| NATCOPHARM | 98.0% | 88.0% | 87.0% | 81.0% | |
| LINCOLN | 97.0% | 88.0% | 80.0% | 81.0% | |
| UNIVPHOTO | 97.0% | 86.0% | 74.0% | 94.0% | |
| VENUSREM | 96.0% | 68.0% | 94.0% | 99.0% | |
| STAR | 96.0% | 73.0% | 91.0% | 91.0% | |
| HALEOSLABS | 95.0% | 82.0% | 77.0% | 81.0% | |
| AUROPHARMA | 94.0% | 71.0% | 84.0% | 87.0% | |
| SAGILITY | 93.0% | 76.0% | 81.0% | 76.0% |
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
15.0% avg (7 factors)
Quality
C
57.1% avg (7 factors)
Risk
B
60.0% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.050 | —1 | — | |
| Value %ile | 0.080 | —1 | — | |
| Quality %ile | 0.160 | —1 | — | |
| Momentum %ile | 0.540 | —0 | — | |
| F-Score | 4.000 | —1 | — | |
| Confidence | 0.818 | —1 | — | |
| Volatility | 0.340 | —0 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
60.58
Earnings Yield (E/P)
0.0165
Price / Sales
10.91
Price / Book
4.09
FCF Yield
-15.0%
EBITDA / EV
2.9%
Sales Yield (1/P·S)
0.0903
Shareholder Yield
Div + net buyback / mktcap
-24.3%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
6.8%
Return on Assets
5.7%
Net Margin
18.0%
Operating Margin
25.4%
Gross Profit / Assets
Novy-Marx GPA
28.0%
Current Ratio
3.76
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.070
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
103.8%
Earnings Growth (YoY)
64.6%
Earnings Stability (CV)
Lower = more stable
0.655
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
-24.3%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
87
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
94
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
94
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity